IRIS
CIANI, ORIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.326
NA - Nord America 4.260
AS - Asia 2.492
SA - Sud America 243
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 20
Totale 13.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.017
IT - Italia 2.720
IE - Irlanda 1.111
SG - Singapore 756
CN - Cina 608
GB - Regno Unito 461
UA - Ucraina 421
RU - Federazione Russa 351
HK - Hong Kong 346
DE - Germania 333
CA - Canada 226
SE - Svezia 224
FI - Finlandia 216
BR - Brasile 212
TR - Turchia 203
VN - Vietnam 149
FR - Francia 108
KR - Corea 77
NL - Olanda 77
ID - Indonesia 68
IL - Israele 66
IN - India 61
BG - Bulgaria 55
CZ - Repubblica Ceca 52
KZ - Kazakistan 49
BE - Belgio 36
AT - Austria 21
RO - Romania 21
ES - Italia 20
AU - Australia 18
IR - Iran 18
EU - Europa 17
CH - Svizzera 15
MX - Messico 15
PL - Polonia 13
PT - Portogallo 13
AE - Emirati Arabi Uniti 12
DK - Danimarca 11
EC - Ecuador 10
JP - Giappone 10
MA - Marocco 10
NO - Norvegia 8
PK - Pakistan 8
LV - Lettonia 7
AR - Argentina 6
HU - Ungheria 6
LT - Lituania 6
PH - Filippine 6
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
GR - Grecia 5
KG - Kirghizistan 5
PE - Perù 5
UZ - Uzbekistan 5
BD - Bangladesh 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
LK - Sri Lanka 3
ZA - Sudafrica 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CO - Colombia 2
EE - Estonia 2
GE - Georgia 2
IQ - Iraq 2
KE - Kenya 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CD - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
DZ - Algeria 1
GH - Ghana 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
PY - Paraguay 1
SM - San Marino 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.389
Salva come PNG Salva come JPEG
Città #
Dublin 1.107
Chandler 673
Milan 606
Singapore 411
Hong Kong 344
Jacksonville 334
Ann Arbor 258
Southend 215
Rome 196
Toronto 189
Redmond 149
New York 147
Dearborn 146
Helsinki 140
Beijing 139
The Dalles 137
Dong Ket 130
Ashburn 126
Wilmington 116
Houston 111
Lawrence 97
Modena 94
Boston 90
Boardman 84
Seoul 71
Izmir 70
Los Angeles 68
Moscow 68
Jakarta 67
Tel Aviv 65
Naples 56
Redwood City 50
Almaty 49
Mountain View 48
Palombara Sabina 47
Seattle 41
Frankfurt am Main 40
Woodbridge 40
Fairfield 36
Bologna 35
Munich 35
Bari 30
Brussels 30
Lappeenranta 28
Fremont 27
Turin 26
Genoa 24
Florence 23
Ottawa 23
Brno 20
Catania 19
Nuremberg 19
Washington 18
Bucharest 16
Hefei 16
Kunming 16
Nanjing 16
Düsseldorf 15
Falkenstein 15
West Jordan 15
Guangzhou 14
Trieste 14
Chennai 13
Dallas 13
Jinan 13
Palermo 13
Vienna 13
Assago 12
Council Bluffs 12
Robbiate 12
São Paulo 12
Napoli 11
Padova 11
Trento 11
Amsterdam 10
Belo Horizonte 10
Bonndorf 10
Falls Church 10
Norwalk 10
Rio de Janeiro 10
Serino 10
Shenyang 10
Torino 10
Venice 10
Darwin 9
London 9
Monza 9
Nardò 9
Paris 9
Verona 9
Bergamo 8
Lisbon 8
Pavia 8
Perugia 8
Santa Clara 8
Ardabil 7
Auburn Hills 7
Brescia 7
Carrara 7
Catanzaro 7
Totale 7.724
Salva come PNG Salva come JPEG
Nome #
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 342
Esiti di salute e performance del Servizio Sanitario Nazionale 336
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 316
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 267
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 255
EQ-5D-5L population norms for Italy 240
I dispositivi medici in Italia: un settore, tanti mercati 236
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 221
Gli esiti di salute del Servizio Sanitario Nazionale 187
Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis 181
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 177
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration 173
Surrogate endpoints: a key concept in clinical epidemiology 167
Endpoint surrogati e politiche sanitarie: l’importanza di metodi di validazione adeguati 167
Current and Future Trends in the HTA of Medical Devices 166
Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis 165
Gli esiti di salute del Servizio Sanitario Nazionale 161
La dimensione del settore dei dispositivi medici 160
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 160
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 150
Surrogate endpoints in health technology assessment: an international review of methodological guidelines 142
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 141
The Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer 139
Integrating HTA principles into procurement of medical devices: the Italian national HTA programme for medical devices 138
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 128
Valutare l’impatto dell’HTA come strumento di governo dell’innovazione tecnologica: modelli teorici e studi empirici 127
Core outcome set in surgical oncology: why, what and how to measure 126
Patient-reported outcome measures in core outcome sets targeted overlapping domains but through different instruments 126
A scoping review of core outcome sets and their 'mapping' onto real-world data using prostate cancer as a case study 123
An economic perspective on urinary tract infection: the "costs of resignation" 122
A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement 122
I processi di valutazione dei dispositivi medici e delle tecnologie sanitarie 121
Comparing drug and non-drug technologies in comparative effectiveness research 121
An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study 121
Mud-bath therapy in addition to usual care in bilateral knee osteoarthritis: economic evaluation alongside a randomized controlled trial 117
Measuring value in health care: a comparative analysis of value-based frameworks 116
Distinguishing features in the assessment of mHealth apps 116
Cost–effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma 114
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 111
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 110
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 108
Broadening the concept of value: a scoping review on the option value of medical technologies 108
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 108
Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer 107
Time to review the role of surrogate end points in health policy: state of the art and the way forward 106
European diabetes research and its funding, 2002–2013 105
The rise of rules: will the new regulation of medical devices make us safer? 105
Hospital-based HTA: quale valore per la valutazione delle tecnologie nelle Aziende Sanitarie italiane? 104
Exercise training for chronic heart failure (ExTraMATCH II): why all data are not equal 104
The evaluation of medical devices: are we getting closer to solve the puzzle? A review of recent trends 102
Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study 101
Introduction to economic evaluation and health technology assessment 101
Coverage with evidence development for medical devices in Europe: can practice meet theory? 101
Harnessing digital health technologies during and after the COVID-19 pandemic: context matters 99
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy. 99
Health technology assessment methods guidelines for medical devices: how can we address the gaps? the international federation of medical and biological engineering perspective 98
Determinants of demand for total hip and and knee arthroplasty: a systematic literature review 97
La gestione dell'innovazione tecnologica in sanità: analisi e confronto di alcune politiche regionali in Italia 97
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis 97
Esiti di salute e performance del Servizio Sanitario Nazionale 97
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study 95
Complete cytogenetic response and major molecular response as surrogate outcomes for overall survival in first-line treatment of chronic myelogenous leukemia: a case study for technology appraisal on the basis of surrogate outcomes evidence 95
Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms 95
Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials 95
Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials 93
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges 93
Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany 92
A more evidence based approach to the use of surrogate end points in policy making 91
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework 90
The impacts of diabetes research from 31 European Countries in 2002 to 2013 90
Mapping payment and pricing schemes for health innovation: protocol of a scoping literature review 90
Urinary Tract Infections – An Economic Issue 89
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study 89
Response to COVID-19: was Italy (un)prepared? 89
Value-based healthcare: il nuovo approccio di AIFA alla determinazione multidimensionale del valore 88
Assessment of nonfatal myocardial infarction as a surrogate for all-cause and cardiovascular mortality in treatment or prevention of coronary artery disease: a meta-analysis of randomized clinical trials 87
Corona-regionalism? Differences in regional responses to COVID-19 in Italy 87
Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps 86
Health technology assessment of medical devices: a survey of non-European union agencies 85
Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses 85
Validation of surrogate end points for overall survival in advanced colorectal cancer: a harmonized approach is needed 84
Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer 84
Quantitative body movement and gesture assessment in ergonomics. 83
Valorizzare gli esiti riferiti dal paziente : opportunità e sfide 81
Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers 81
Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis 80
Linking the regulatory and reimbursement processes for medical devices: the need for integrated assessments 80
Esiti di salute e performance del Servizio Sanitario Nazionale 76
Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials 76
Pervasive technology in Neonatal Intensive Care Unit: a prototype for newborns unobtrusive monitoring 73
Value lies in the eye of the patients: the why, what, and how of patient-reported outcomes measures 72
The role of health technology assessment bodies in shaping drug development 71
A call for better reporting of trials using surrogate primary endpoints 70
Strumenti a supporto del processo decisionale condiviso in oncologia 67
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 66
Esiti di salute e performance del Servizio Sanitario Nazionale 65
The Coronavirus pandemic and inequality in Italy 65
Editorial: Near-infrared fluorescence guided surgery: state of the evidence from a health technology assessment perspective 60
Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis 60
The impact of surgical experience in VATS lobectomy on conversion and patient quality of life: results from a comprehensive national video-assisted thoracic surgical database 59
Totale 12.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 0 0 0 0 0 0 0 0 0 0 39 140
2020/20211.350 59 86 33 106 143 91 129 58 156 118 116 255
2021/20221.500 107 220 50 68 140 66 58 233 72 145 143 198
2022/20233.178 202 173 86 266 203 223 83 162 1.398 121 161 100
2023/20242.436 109 142 149 59 258 287 193 324 98 180 303 334
2024/20252.839 108 71 228 172 179 195 276 245 961 384 20 0
Totale 13.832